Table 2.
Lung [18F]FDG PET and high-resolution CT (HRCT) analysis in IPF patients
| Controls | IPF patients | ||||
|---|---|---|---|---|---|
| Global | Global | Right lung | Left lung | P value | |
| [18F]FDG PET analysis | |||||
| SUV max | 1.84 ± 0.82 | 3.8 ± 2.5 | 3.7 ± 2.5 | 3.9 ± 2.5 | 0.45 |
| SUV mean | 0.50 ± 0.11 | 1.0 ± 0.4 | 1.0 ± 0.5 | 1.0 ± 0.3 | 0.57 |
| TLG (cm3) | 0 | 1426 ± 1030 | |||
| MLV (cm3) | 0 | 950 ± 571 | |||
| HRCT analysis | |||||
| Fibrosis score | NA | 8.2 ± 3.0 | 8.4 ± 3.1 | 7.9 ± 3.0 | 0.86 |
| Ground-glass score | NA | 2.8 ± 1.9 | 2.6 ± 1.9 | 3.0 ± 2.0 | 0.65 |
Data are mean ± SD. In controls, HRCT was not performed and global [18F]FDG uptake was quantified. NA: data not available